Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 versus valsartan for cognitive function in HFpEF
NL-OMON50528Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sacubitril + valsartan and valsartan, sponsored by Novartis. Started Sep 2017; status: active, not recruiting.
02
Drugs
sacubitril + valsartanvalsartan
Beyond the preview
Go deeper on NL-OMON50528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50528.